Institutions / MPM BioImpact LLC
MPM BioImpact LLC
CIK 1687078 · Institution · as of Dec 31, 2025
Portfolio value
$873.95M
Positions
38
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 38 →
| Company | Value | % of portfolio |
|---|---|---|
| Cullinan Therapeutics, Inc. | $79.16M | 9.1% |
| Madrigal Pharmaceuticals, Inc. | $56.36M | 6.4% |
| Liquidia CorpLQDA | $48.32M | 5.5% |
| Trevi Therapeutics, Inc. | $41.15M | 4.7% |
| Edgewise Therapeutics, Inc. | $41.08M | 4.7% |
| Revolution Medicines, Inc. | $40.28M | 4.6% |
| Agios Pharmaceuticals, Inc. | $35.48M | 4.1% |
| Uniqure NV | $33.06M | 3.8% |
| PTC Therapeutics Inc | $32.66M | 3.7% |
| Syndax Pharmaceuticals Inc | $28.11M | 3.2% |
| Dyne Therapeutics, Inc. | $27.49M | 3.1% |
| Tarsus Pharmaceuticals, Inc. | $26.93M | 3.1% |
| Stoke Therapeutics, Inc. | $24.45M | 2.8% |
| Alumis Inc.ALMS | $23.44M | 2.7% |
| Urogen Pharma Ltd | $22.05M | 2.5% |
| Xenon Pharmaceuticals Inc. | $21.77M | 2.5% |
| Palvella Therapeutics, Inc.PVLA | $21.54M | 2.5% |
| Natera, Inc. | $21.43M | 2.5% |
| Corvus Pharmaceuticals, Inc. | $21.13M | 2.4% |
| Dbv Technologies S.A.DBVT | $19.11M | 2.2% |
| Relay Therapeutics, Inc. | $18.89M | 2.2% |
| Monte Rosa Therapeutics, Inc. | $18.40M | 2.1% |
| Bright Minds Biosciences Inc. | $17.96M | 2.1% |
| Protagonist Therapeutics Inc | $17.42M | 2.0% |
| enGene Therapeutics Inc. | $16.62M | 1.9% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.